EMERGENT BIOSOLUTIONS INC. Amortization of Intangible Assets
EMERGENT BIOSOLUTIONS INC. (EBS) reported Amortization of Intangible Assets of $17.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for the quarter ending 2026-06-30 was $17.20M, a 6.17% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for the quarter ending 2026-03-31 was $16.50M, a 1.23% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for the quarter ending 2025-12-31 was $16.30M, a 0.00% change year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for the quarter ending 2025-09-30 was $16.30M, a 0.00% change year-over-year.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for fiscal 2025 was $65.10M, a 0.00% change from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for fiscal 2024 was $65.10M, a 0.76% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for fiscal 2023 was $65.60M, a 9.52% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. amortization of intangible assets for fiscal 2022 was $59.90M, a 2.39% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.20M 10-Q · filed 2026-08-06 | $33.70M 10-Q · filed 2026-08-06 | $50.00M derived: sum of 3 quarters · filed 2026-08-06 | $66.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $16.50M 10-Q · filed 2026-05-01 | $32.80M derived: sum of 2 quarters · filed 2026-05-01 | $49.10M derived: sum of 3 quarters · filed 2026-05-01 | $65.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $32.60M derived: sum of 2 quarters · filed 2026-02-27 | $48.80M derived: sum of 3 quarters · filed 2026-08-06 | $65.10M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $16.30M 10-Q · filed 2025-10-30 | $32.50M derived: sum of 2 quarters · filed 2026-08-06 | $48.80M 10-Q · filed 2025-10-30 | $65.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $16.20M 10-Q · filed 2026-08-06 | $32.50M 10-Q · filed 2026-08-06 | $48.80M derived: sum of 3 quarters · filed 2026-08-06 | $65.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $16.30M 10-Q · filed 2026-05-01 | $32.60M derived: sum of 2 quarters · filed 2026-05-01 | $48.90M derived: sum of 3 quarters · filed 2026-05-01 | $65.20M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $32.60M derived: sum of 2 quarters · filed 2026-02-27 | $48.90M derived: sum of 3 quarters · filed 2026-02-27 | $65.10M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $16.30M 10-Q · filed 2025-10-30 | $32.60M derived: sum of 2 quarters · filed 2025-10-30 | $48.80M 10-Q · filed 2025-10-30 | $65.00M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $16.30M 10-Q · filed 2025-08-07 | $32.50M 10-Q · filed 2025-08-07 | $48.70M derived: sum of 3 quarters · filed 2026-02-27 | $65.00M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $16.20M 10-Q · filed 2025-05-08 | $32.40M derived: sum of 2 quarters · filed 2026-02-27 | $48.70M derived: sum of 3 quarters · filed 2026-02-27 | $64.80M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $32.50M derived: sum of 2 quarters · filed 2026-02-27 | $48.60M derived: sum of 3 quarters · filed 2026-02-27 | $65.60M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $16.30M 10-Q · filed 2024-11-07 | $32.40M derived: sum of 2 quarters · filed 2024-11-07 | $49.40M 10-Q · filed 2024-11-07 | $67.30M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $16.10M 10-Q · filed 2024-08-07 | $33.10M 10-Q · filed 2024-08-07 | $51.00M derived: sum of 3 quarters · filed 2025-03-04 | $65.00M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-03-31 | $17.00M 10-Q · filed 2024-05-02 | $34.90M derived: sum of 2 quarters · filed 2025-03-04 | $48.90M derived: sum of 3 quarters · filed 2025-03-04 | $62.90M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2022-12-31 | $17.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $31.90M derived: sum of 2 quarters · filed 2025-03-04 | $45.90M derived: sum of 3 quarters · filed 2025-03-04 | $59.90M 10-K · filed 2025-03-04 | ||||
| 2022-09-30 | $14.00M 10-Q · filed 2023-12-11 | $28.00M derived: sum of 2 quarters · filed 2023-12-11 | $42.00M 10-Q · filed 2023-12-11 | $56.00M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $14.00M 10-Q · filed 2023-08-09 | $28.00M 10-Q · filed 2023-08-09 | $42.00M derived: sum of 3 quarters · filed 2024-03-08 | $56.50M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $14.00M 10-Q · filed 2023-05-10 | $28.00M derived: sum of 2 quarters · filed 2024-03-08 | $42.50M derived: sum of 3 quarters · filed 2024-03-08 | $57.60M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $28.50M derived: sum of 2 quarters · filed 2024-03-08 | $43.60M derived: sum of 3 quarters · filed 2024-03-08 | $58.50M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $14.50M 10-Q · filed 2022-11-09 | $29.60M derived: sum of 2 quarters · filed 2022-11-09 | $44.50M 10-Q · filed 2022-11-09 | $59.50M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $15.10M 10-Q · filed 2022-08-02 | $30.00M 10-Q · filed 2022-08-02 | $45.00M derived: sum of 3 quarters · filed 2023-12-11 | $60.00M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $14.90M 10-Q · filed 2022-04-29 | $29.90M derived: sum of 2 quarters · filed 2023-12-11 | $44.90M derived: sum of 3 quarters · filed 2023-12-11 | $59.90M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $15.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $30.00M derived: sum of 2 quarters · filed 2023-12-11 | $45.00M derived: sum of 3 quarters · filed 2023-12-11 | $59.80M 10-K/A · filed 2023-12-11 | ||||
| 2020-09-30 | $15.00M 10-Q · filed 2021-11-05 | $30.00M derived: sum of 2 quarters · filed 2021-11-05 | $44.80M 10-Q · filed 2021-11-05 | $59.60M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $15.00M 10-Q · filed 2021-07-30 | $29.80M 10-Q · filed 2021-07-30 | $44.60M derived: sum of 3 quarters · filed 2022-02-25 | $59.30M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $14.80M 10-Q · filed 2021-04-30 | $29.60M derived: sum of 2 quarters · filed 2022-02-25 | $44.30M derived: sum of 3 quarters · filed 2022-02-25 | $59.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $14.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $29.50M derived: sum of 2 quarters · filed 2022-02-25 | $44.20M derived: sum of 3 quarters · filed 2022-02-25 | $58.70M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $14.70M 10-Q · filed 2020-11-06 | $29.40M derived: sum of 2 quarters · filed 2020-11-06 | $43.90M 10-Q · filed 2020-11-06 | $57.20M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $14.70M 10-Q · filed 2020-07-31 | $29.20M 10-Q · filed 2020-07-31 | $42.50M derived: sum of 3 quarters · filed 2021-02-19 | $46.40M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $14.50M 10-Q · filed 2020-05-01 | $27.80M derived: sum of 2 quarters · filed 2021-02-19 | $31.70M derived: sum of 3 quarters · filed 2021-02-19 | $35.60M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $17.20M derived: sum of 2 quarters · filed 2021-02-19 | $21.10M derived: sum of 3 quarters · filed 2021-02-19 | $25.00M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $3.90M 10-Q · filed 2019-11-07 | $7.80M derived: sum of 2 quarters · filed 2019-11-07 | $11.70M 10-Q · filed 2019-11-07 | $15.60M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $3.90M 10-Q · filed 2019-08-02 | $7.80M 10-Q · filed 2019-08-02 | $11.70M derived: sum of 3 quarters · filed 2020-02-25 | $13.30M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $3.90M 10-Q · filed 2019-05-08 | $3.91M 10-Q · filed 2018-05-04 | $7.80M derived: sum of 2 quarters · filed 2020-02-25 | $9.40M derived: sum of 3 quarters · filed 2020-02-25 | $11.00M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $5.50M derived: sum of 2 quarters · filed 2020-02-25 | $7.10M derived: sum of 3 quarters · filed 2020-02-25 | $8.60M 10-K · filed 2020-02-25 | $8.57M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $1.60M 10-Q · filed 2018-11-02 | $1.55M 10-Q · filed 2017-11-03 | $3.20M derived: sum of 2 quarters · filed 2018-11-02 | $4.70M 10-Q · filed 2018-11-02 | $4.66M 10-Q · filed 2017-11-03 | $6.42M derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2017-06-30 | $1.60M 10-Q · filed 2018-08-03 | $1.55M 10-Q · filed 2017-08-04 | $3.10M 10-Q · filed 2018-08-03 | $3.11M 10-Q · filed 2017-08-04 | $4.82M derived: sum of 3 quarters · filed 2019-02-22 | $6.47M derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2017-03-31 | $1.55M 10-Q · filed 2018-05-04 | $3.22M derived: sum of 2 quarters · filed 2019-02-22 | $4.87M derived: sum of 3 quarters · filed 2019-02-22 | $6.71M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $3.31M derived: sum of 2 quarters · filed 2019-02-22 | $5.16M derived: sum of 3 quarters · filed 2019-02-22 | $7.00M 10-K · filed 2019-02-22 | $6.89M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $1.65M 10-Q · filed 2017-11-03 | $3.49M derived: sum of 2 quarters · filed 2017-11-03 | $5.34M 10-Q · filed 2017-11-03 | $7.18M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $1.84M 10-Q · filed 2017-08-04 | $2.37M 10-Q · filed 2016-08-05 | $3.69M 10-Q · filed 2017-08-04 | $4.73M 10-Q · filed 2016-08-05 | $5.53M derived: sum of 3 quarters · filed 2018-02-23 | $7.37M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $1.84M 10-Q · filed 2017-05-05 | $2.36M 10-Q · filed 2016-05-06 | $3.69M derived: sum of 2 quarters · filed 2018-02-23 | $5.53M derived: sum of 3 quarters · filed 2018-02-23 | $7.92M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $3.69M derived: sum of 2 quarters · filed 2018-02-23 | $6.08M derived: sum of 3 quarters · filed 2018-02-23 | $7.38M 10-K · filed 2018-02-23 | $9.27M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $1.84M 10-Q · filed 2016-11-09 | $2.37M 10-Q · filed 2015-11-06 | $4.24M derived: sum of 2 quarters · filed 2016-11-09 | $5.53M 10-Q · filed 2016-11-09 | $6.91M 10-Q · filed 2015-11-06 | $7.29M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $2.39M 10-Q · filed 2016-08-05 | $4.53M 10-Q · filed 2016-08-05 | $5.44M derived: sum of 3 quarters · filed 2017-02-28 | $7.66M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $2.14M 10-Q · filed 2016-05-06 | -$2.14M 10-Q · filed 2015-05-08 | $3.05M derived: sum of 2 quarters · filed 2017-02-28 | $5.26M derived: sum of 3 quarters · filed 2017-02-28 | $7.51M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.12M derived: sum of 2 quarters · filed 2017-02-28 | $5.37M derived: sum of 3 quarters · filed 2017-02-28 | $6.99M 10-K · filed 2017-02-28 | -$8.00M 10-K · filed 2015-03-09 | |||
| 2014-09-30 | $2.21M 10-Q · filed 2015-11-06 | -$6.08M 10-Q · filed 2014-11-10 | $4.46M derived: sum of 2 quarters · filed 2015-11-06 | $6.08M 10-Q · filed 2015-11-06 | ||||
| 2014-06-30 | $2.25M 10-Q · filed 2015-08-06 | -$3.87M 10-Q · filed 2014-08-08 | $3.87M 10-Q · filed 2015-08-06 | |||||
| 2014-03-31 | -$1.64M 10-Q · filed 2015-05-08 | -$1.62M 10-Q · filed 2014-05-12 | ||||||
| 2013-12-31 | $1.95M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |